Cnb Bank Biogen Inc. Transaction History

Cnb Bank

$213 Million
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $7,982 - $11,006	-41 Reduced 50.62%	40 $11,000
Q2 2022 Aug 19, 2022	SELL	$187.54 - $223.02 $18,754 - $22,302	-100 Reduced 55.25%	81 $17,000
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $18,754 - $22,302	100 Added 123.46%	181 $37,000
Q1 2022 Apr 13, 2022	SELL	$193.77 - $244.14 $1,356 - $1,708	-7 Reduced 7.95%	81 $17,000
Q4 2021 Jan 31, 2022	SELL	$223.92 - $287.77 $30,005 - $38,561	-134 Reduced 60.36%	88 $21,000
Q3 2021 Nov 02, 2021	SELL	$282.99 - $369.05 $29,996 - $39,119	-106 Reduced 32.32%	222 $63,000
Q2 2021 Jul 29, 2021	SELL	$259.0 - $414.71 $29,008 - $46,447	-112 Reduced 25.45%	328 $114,000
Q1 2021 May 03, 2021	SELL	$242.95 - $284.63 $728 - $853	-3 Reduced 0.68%	440 $123,000
Q4 2020 Jan 27, 2021	BUY	$236.26 - $355.63 $236 - $355	1 Added 0.23%	443 $108,000
Q3 2020 Oct 26, 2020	SELL	$264.77 - $305.71 $36,008 - $41,576	-136 Reduced 23.53%	442 $125,000
Q2 2020 Jul 14, 2020	SELL	$258.66 - $342.55 $5,949 - $7,878	-23 Reduced 3.83%	578 $155,000
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $84,150 - $106,745	-313 Reduced 34.25%	601 $190,000
Q4 2019 Jan 27, 2020	SELL	$220.06 - $304.07 $44,232 - $61,118	-201 Reduced 18.03%	914 $271,000
Q3 2019 Nov 04, 2019	SELL	$217.44 - $243.88 $126,984 - $142,425	-584 Reduced 34.37%	1,115 $260,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $36,621 - $40,367	-167 Reduced 8.95%	1,699 $398,000
Q1 2019 Apr 29, 2019	BUY	$216.71 - $338.96 $39,007 - $61,012	180 Added 10.68%	1,866 $441,000
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $75,473 - $95,595	271 Added 19.15%	1,686 $507,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $47,255 - $61,796	-161 Reduced 10.22%	1,415 $500,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $1,545 - $1,841	6 Added 0.38%	1,576 $458,000
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $83,761 - $118,467	322 Added 25.8%	1,570 $429,000
Q4 2017 Feb 20, 2018	BUY	$307.64 - $344.58 $383,934 - $430,035	1,248	1,248 $398,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

126M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cnb Bank with notifications on news.

Account